Harvard Bioscience: Of The Current Report On Form 8k Filed By Harvard Bioscience, Inc. (the "company") With The Securities And Exchange Commission On June 23, 2025 (the "original Form 8k") To Add That On June 26, 2025, The Company Received A Letter From The Staff (as Defined Below) Notifying The Company That The Staff Had Determined That The Company No Longer Complies With The Audit Committee Composition Requirement (as Defined Below) As Identified In The Original Form 8k. Item 3.01 Of The Original Form 8k Is Hereby Restated In Its Entirety, Financial Statements And Exh

Show full article

This functionality is available for registred users only

• Full name
  Harvard Bioscience Inc.
• Registration country
  USA
• Industry
  IT Services and Computer Programming
• М/S&P/F
  *** / *** / ***